# Inhibikase Therapeutics Inc. (IKT) — EPS

## Annual EPS (USD)

| Year | EPS (diluted) |
| --- | --- |
| 2024 | $-1.16 |
| 2023 | $-3.16 |
| 2022 | $-4.28 |
| 2021 | $-0.81 |

## Quarterly EPS (USD)

| Quarter | EPS (diluted) |
| --- | --- |
| 2026-03-31 | $-0.10 |
| 2025-09-30 | $-0.13 |
| 2025-06-30 | $-0.11 |
| 2025-03-31 | $-0.15 |
| 2024-09-30 | $-0.65 |
| 2024-06-30 | $-0.66 |
| 2024-03-31 | $-0.73 |
| 2023-09-30 | $-0.86 |
| 2023-06-30 | $-1.11 |
| 2023-03-31 | $-0.98 |
| 2022-09-30 | $-1.06 |
| 2022-06-30 | $-1.10 |
| 2022-03-31 | $-0.18 |
| 2021-09-30 | $-0.18 |
| 2021-06-30 | $-0.22 |

Source: [CompaniesByCap](https://companiesbycap.com/company/IKT/eps)